Brain atrophy measured by MRI is an important correlate with clinical disability and disease duration in multiple sclerosis (MS). Unfortunately, neuropathologic mechanisms which lead to this grey matter atrophy remain unknown. The objective of this study was to determine whether brain atrophy occurs in the mouse model, experimental autoimmune encephalomyelitis (EAE). Postmortem high-resolution T2-weighted magnetic resonance microscopy (MRM) images from 32 mouse brains (21 EAE and 11 control) were collected. A minimum deformation atlas was constructed and a deformable atlas approach was used to quantify volumetric changes in neuroanatomical structures. A significant decrease in the mean cerebellar cortex volume in mice with late EAE (48–56 d...
Multiple Sclerosis (MS) is an inflammatory demyelinating disease affecting the grey matter (GM) and ...
Studies of MS histopathology are largely dependent on suitable animal models. While light microscopi...
Background Brain atrophy is a well-accepted imaging biomarker of multiple sclerosis (MS) that partia...
Brain atrophy measured by MRI is an important correlate with clinical disability and disease duratio...
Gray matter atrophy observed by brain MRI is an important correlate to clinical disability and disea...
Gray matter (GM) atrophy is considered one of the best predictors of disability accumulation in mult...
Gray matter atrophy has been shown to be a strong correlate to clinical disability in multiple scler...
AbstractGray matter atrophy has been shown to be a strong correlate to clinical disability in multip...
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system characterized by dama...
Two general pathological processes contribute to multiple sclerosis (MS: acute inflammation and dege...
<div><p>Inflammatory disorders of the central nervous system such as multiple sclerosis and acute di...
Inflammatory disorders of the central nervous system such as multiple sclerosis and acute disseminat...
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS) characterized b...
<div><p>Background</p><p>Multiple sclerosis (MS) is an autoimmune disease of the central nervous sys...
Background: Cortical atrophy, assessed with magnetic resonance imaging (MRI), is an important outcom...
Multiple Sclerosis (MS) is an inflammatory demyelinating disease affecting the grey matter (GM) and ...
Studies of MS histopathology are largely dependent on suitable animal models. While light microscopi...
Background Brain atrophy is a well-accepted imaging biomarker of multiple sclerosis (MS) that partia...
Brain atrophy measured by MRI is an important correlate with clinical disability and disease duratio...
Gray matter atrophy observed by brain MRI is an important correlate to clinical disability and disea...
Gray matter (GM) atrophy is considered one of the best predictors of disability accumulation in mult...
Gray matter atrophy has been shown to be a strong correlate to clinical disability in multiple scler...
AbstractGray matter atrophy has been shown to be a strong correlate to clinical disability in multip...
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system characterized by dama...
Two general pathological processes contribute to multiple sclerosis (MS: acute inflammation and dege...
<div><p>Inflammatory disorders of the central nervous system such as multiple sclerosis and acute di...
Inflammatory disorders of the central nervous system such as multiple sclerosis and acute disseminat...
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS) characterized b...
<div><p>Background</p><p>Multiple sclerosis (MS) is an autoimmune disease of the central nervous sys...
Background: Cortical atrophy, assessed with magnetic resonance imaging (MRI), is an important outcom...
Multiple Sclerosis (MS) is an inflammatory demyelinating disease affecting the grey matter (GM) and ...
Studies of MS histopathology are largely dependent on suitable animal models. While light microscopi...
Background Brain atrophy is a well-accepted imaging biomarker of multiple sclerosis (MS) that partia...